GlassScriptPhysician profile
Jimmy D Schmidt
NPI 1033194287
$8,359.25
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $1,101 · 2021: $999 · 2022: $1,942 · 2023: $1,999 · 2024: $1,210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,138 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,137.51 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,825.12 | 2019-2024 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $1,722.35 | 2019-2024 | Tremfya, Stelara, Simponi |
| Novartis Pharmaceuticals Corporation | $1,002.40 | 2019-2024 | |
| Genzyme Corporation | $995.50 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $755.14 | 2020-2024 | Dupixent |
| Sun Pharmaceutical Industries INC. | $398.19 | 2019-2024 | Ilumya |
| Ucb, INC. | $380.79 | 2019-2024 | Cimzia, Bimzelx |
| Pfizer INC. | $359.43 | 2019-2022 | |
| Lilly USA, LLC | $209.43 | 2020-2024 | Olumiant, Taltz |
| Leo Pharma INC. | $142.75 | 2019-2023 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $123.77 | 2022-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $94.19 | 2022-2024 | Aklief, Oracea, Twyneo |
| Incyte Corporation | $65.66 | 2022-2024 | Opzelura |
| Amgen INC. | $54.49 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.50 | 2023-2024 | Spevigo, Cyltezo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $46.83 | 2019 | |
| Dermavant Sciences, INC. | $33.31 | 2023 | Vtama |
| Sandoz INC. | $32.16 | 2023 | Hyrimoz |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $26.14 | 2019-2022 | |
| Almirall LLC | $24.84 | 2024 | Seysara |
| Kerecis Limited | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.